Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

39.46
-1.3600-3.33%
Volume:805.00K
Turnover:32.04M
Market Cap:8.14B
PE:-14.00
High:41.37
Open:40.60
Low:39.20
Close:40.82
52wk High:45.42
52wk Low:14.58
Shares:206.40M
Float Shares:89.57M
Volume Ratio:0.92
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8178
EPS(LYR):-2.7716
ROE:-80.10%
ROA:-46.73%
PB:11.08
PE(LYR):-14.24

Loading ...

Aug 02, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 13, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 01, 2021

Major Issues Report

8-K - Current report
Mar 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 17, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 18, 2020

Major Issues Report

8-K - Current report
Sep 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 25, 2020

Major Issues Report

8-K - Current report